CF Clinical Trials Network Praised by The Columbus Dispatch
| 1 min read

A column in The Columbus Dispatch recognizes the Cystic Fibrosis Foundation Therapeutics Development Network and its impact on treating children with rare diseases. The clinical trials network has been “very successful in shaping the care of children” and “markedly improving life spans,” the story says. The network has served as a model for many other pediatric research networks, including inflammatory-bowel disease, heart disease, critical care, and emergency department care. 

Learn more about the Therapeutics Development Network.

Share this article
Topics
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Clinical Trials
Recent news
CF Foundation Provides Up to $3.9M to TB Alliance to Further Develop an NTM Drug
News | 2 min read
CF Foundation Advocates to Protect Needs of People With CF in Post-Pandemic Medicaid Redeterminations
News | 5 min read
FDA Approves Kalydeco for Infants as Young as 1 Month
News | 4 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe